HOXA10 and nasopharyngeal carcinoma: This supports previous evidence of HOXA10-AS promoting tumor invasion in various cancers, including gastric cancer [41], lung adenocarcinoma [42], esophageal carcinoma [27], and nasopharyngeal cancer [43].